The FDA has approved Onivyde (irinotecan liposome injection) from Merrimack Pharma, in combination with fluorouracil and leucovorin, to treat patients...
Fluorouracil Injection, 50 mg/ml, solution for injection, may be used alone or in combination, for its palliative action in the management of common malignancies particularly cancer of the colon and breast, either as single agent or in combination with other cytotoxic agents.